News
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Zentek Announces Promising Preclinical Safety and Toxicity Results achieved by Triera Biosciences Ltd. for C19HBA
Zentek Ltd. announces successful safety and toxicity testing of C19HBA SARS-CoV-2 universal aptamer in preclinical trials, showing promising results for future human therapeutics -
COMMUNIQUÉ DE PRESSE
Zentek Announces Positive Therapeutic Results achieved by Triera Biosciences for C19HBA
Zentek Ltd.'s subsidiary Triera Biosciences completes successful testing of C19HBA aptamer as therapeutic for SARS-CoV-2, outperforming monoclonal antibody in preclinical trials. C19HBA shows potential for prophylaxis and treatment. Future clinical trials and partnerships to be pursued -
COMMUNIQUÉ DE PRESSE
Zentek Completes Study Quantifying Energy and Emission Savings of ZenGUARD(TM)-Enhanced HVAC Filters
Zentek Ltd. announces the completion of a new study showing significant energy and cost savings for commercial buildings adopting ZenGUARDTM Enhanced Air Filters. The study highlights the reduction of infection risk and the potential to reduce HVAC energy consumption and CO2 emissions. Find out more on Zentek's website. -
COMMUNIQUÉ DE PRESSE
Zentek Announces Eric Wallman Appointed as Chairman of the Board
Zentek Ltd., an intellectual property development and commercialization company, announces the resignation of Dr. Francis Dubé as Chairman of the Board and the appointment of Mr. Eric Wallman as the new Chairman according to best practices in governance. The company continues to focus on research, development, and commercialization of novel products, including their patented technology platform, ZenGUARD™, known for its anti-microbial activity and increased filtration efficiency. -
COMMUNIQUÉ DE PRESSE
Zentek Launches Triera Biosciences Ltd.
-
COMMUNIQUÉ DE PRESSE
Zentek and 1Click Heating and Cooling Sign Distribution Agreement
